13 December 2022 - interim results
The AIM-listed specialist infection prevention and control company has announced interim results for the six month period to 30 September. These have revealed a decline in revenues to £2.2m (2021: £3.2m) although last year was still benefiting from some Covid related business. The adjusted pre-tax loss came in at £454k (2021: profit of £44k). Although these figures look disappointing, the business has taken action to improve its performance by focusing on what it regards as key products and sectors and has therefore reduced its operational segments from seven to three, being . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
